Juliana took over the company's face from American actress and model Tatiana Zappardino. Discover more about the New Day USA ...

In fact, Dunkin' commercial mainstay Ben Affleck is nowhere to be found in a new series of ads that stars Will Arnett and ...

Blake Lively is an American actress. She first rose to fame for her role in The Sisterhood of the Traveling Pants franchise. She is perhaps best known for playing Serena Van Der Woodsen on the CW ...

Anna Paquin is a Canadian-New Zealander actress. She won an Academy Award for her performance in 1993's The Piano when she was 11, making her the second youngest winner in Oscar history.

Take advantage of real dealer pricing and shop special offers on new and used boats. Select your boat to get ... Insure your 2000 Terhi USA NORDIC 6020 for just $100/year*. More freedom: You’re ...

The decision is a crucial step in getting shots to the Democratic Republic of Congo, the center of the outbreak. By Stephanie Nolen Drugmakers have supplies ready to ship that are necessary to ...

Alec Baldwin has urged a New Mexico judge to stand by her decision to end his trial and dismiss an involuntary manslaughter charge against the actor in the fatal shooting of a cinematographer on ...

A look at the sheer range of hairstyle that defined the earliest days of America’s contemporary hair industry. Art historian Elizabeth L. Block noticed this, too. Her fascinating new book ...

Copenhagen is at the forefront of a New Nordic culinary scene, while Stock­holm is a hub of ­hipster bars and cafés. And let’s not forget those special ­qualities that make a country unique ...

Shares in Bavarian Nordic BAVA1.35%increase; green up pointing triangle surged Thursday after the Danish Mpox vaccine maker received a new order and reported earnings that beat expectations.

Take advantage of real dealer pricing and shop special offers on new and used boats. Select your boat to get ... Insure your 2002 Terhi USA NORDIC 6020 for just $100/year*. More freedom: You’re ...

Under the deal, Bavarian Nordic could receive as much as $975 million to license its advanced prostate cancer treatment, Prostvac.